AWA
AZN icon

Acorn Wealth Advisors’s AstraZeneca AZN Stock Holding History

Acorn Wealth Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-122
Closed -$9K – 844
2017
Q4 		$9K Buy
+122
New +$8.23K 0.01% 504

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Acorn Wealth Advisors's AZN Position: Q1 2018 in Review

Acorn Wealth Advisors sold out of AstraZeneca (AZN) in Q1 2018, closing a stake of 122 shares — an estimated $9K sold.

Acorn Wealth Advisors first reported a position in AZN in Q4 2017 and held it in 1 quarter. The position peaked at $9K in Q4 2017. 519 funds tracked by Wall St. Rank hold AZN as of Q1 2018.

  • Acorn Wealth Advisors reported no remaining AstraZeneca position as of Q1 2018 after selling out during the quarter.
  • Acorn Wealth Advisors sold 122 AstraZeneca shares in Q1 2018, an estimated $9K.
  • Acorn Wealth Advisors first reported a position in AstraZeneca in Q4 2017 and held it in 1 quarter.
  • Acorn Wealth Advisors's AstraZeneca position peaked at $9K in Q4 2017.
  • 519 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2018.

Based on Acorn Wealth Advisors's 13F filing for Q1 2018, filed 14 May 2018.